Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to ...

The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the ...

The veteran all-star Milwaukee Bucks guard was diagnosed with deep vein thrombosis (a blood clot in his lower ... If left ...

Investigators studied the prevalence and outcomes of venous thromboembolic events (VTEs) among hospitalized patients with and without CKD.

Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...

Purpose: Deep-vein thrombosis (DVT) and pulmonary embolism (PE) are associated with major morbidity and mortality, with their burden often extending to longer-term complications such as event ...

What is the latest injury status of Damian Lillard as the Milwaukee Bucks begin the NBA playoffs in Indianapolis against the ...

Aurobindo Pharma jumped 3.42% to Rs 1,119.55 after the pharma company said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban ...

Aurobindo Pharma said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg.

IRISH people are being alerted to a killer condition that may be sparked when travelling for hours. As the Easter break approaches, many of us will be preparing for a trip away.  There are 4,000 ...

Aurobindo Pharma gains FDA approval to manufacture and market Rivaroxaban Tablets USP, with plans to launch by June.

Total hip replacement (THR) surgery has become less invasive thanks to new surgical techniques and modern implants. As a ...